Eruptions in Patients with chronic hepatitis C receiving combination therapy with Telaprevir, Peginterferon and Ribavirin

被引：0
|
作者：
Eleftheriadis, V [1 ]
Stadler, R. [1 ]
机构：
[1] Johannes Wesling Klinikum Minden, Hautklin, Minden, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2012年 / 10卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：869 / 869
页数：1
相关论文
共 50 条
  • [41] Retreatment with peginterferon and ribavirin in chronic hepatitis C
    Jo, Yong Min
    Lee, Sung Wook
    Han, Sang Young
    Baek, Yang Hyun
    Kim, Soo Young
    Kim, Woo Jae
    Ahn, Ji Hye
    Lee, Ji Young
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (06) : 1994 - 1999
  • [42] Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin
    Valenti, L.
    Aghemo, A.
    Staettermayer, A. F.
    Maggioni, P.
    De Nicola, S.
    Motta, B. M.
    Rumi, M. G.
    Dongiovanni, P.
    Ferenci, P.
    Colombo, M.
    Fargion, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (12) : 1434 - 1442
  • [43] UTILIZATION AND COST OF PEGINTERFERON PLUS RIBAVIRIN COMBINATION THERAPY IN THE MANAGEMENT OF CHRONIC HEPATITIS C VIRUS IN EUROPE
    Davis, K. L.
    Mitra, D.
    Leteneux, C.
    Bapat, B.
    Naujoks, C.
    VALUE IN HEALTH, 2010, 13 (03) : A73 - A74
  • [44] ANALYSIS OF CAUSES OF RESPONSE FAILURE IN NAiVE PATIENTS WITH CHRONIC HEPATITIS C RECEIVING PEGINTERFERON PLUS RIBAVIRIN
    Garcia-Retortillo, Montserrat
    Maria Morillas, Rosa
    Miquel, Mireia
    Rodriguez-Lopez, Olga
    Cirera, Isabel
    Vergara, Mercedes
    Masnou, Helena
    Dolors Gimenez, M.
    Canete, Nuria
    Gallach, Marta
    Ardevol, Merce
    Antonio Alvarez, Marco
    Montoliu, Silvia
    Romero-Gomez, Manuel
    Planas, Ramon
    Sola, Ricard
    HEPATOLOGY, 2009, 50 (04) : 727A - 727A
  • [45] Peginterferon Lambda-1a/Ribavirin with Daclatasvir or Peginterferon Alfa-2a/Ribavirin with Telaprevir for Chronic Hepatitis C Genotype 1b
    Flisiak, Robert
    Kawazoe, Seiji
    Znoyko, Olga
    Assy, Nimer
    Gadano, Adrian
    Kao, Jia-Horng
    Lee, Kwan-Sik
    Zwirtes, Ricardo
    Portsmouth, Simon
    Dong, Yuping
    Xu, Dong
    Kumada, Hiromitsu
    Srinivasan, Subasree
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2016, 36 (11): : 635 - 643
  • [46] Combination therapy for chronic hepatitis C: interferon and ribavirin
    Christie, JML
    Chapman, RWG
    HOSPITAL MEDICINE, 1999, 60 (05): : 357 - 361
  • [47] Peginterferon Alfa 2a/ribavirin versus Peginterferon Alfa 2b/ribavirin combination therapy in chronic Hepatitis C genotype 3
    Khan, Arif Q.
    Awan, Ali
    Shahbuddin, Sultan
    Igbal, Qamar
    GASTROENTEROLOGY, 2007, 132 (04) : A200 - A200
  • [48] Incidence of Depression in Patients with Chronic Hepatitis C Receiving Combination Therapy of Pegylated Interferon-Alpha and Ribavirin
    Mahajan, Sudhir
    Avasthi, Ajit
    Grover, Sandeep
    Chawla, Yogesh K.
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2014, 83 (05) : 308 - 309
  • [49] Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C -: A randomized study of treatment duration and ribavirin dose
    Hadziyannis, SJ
    Sette, H
    Morgan, TR
    Balan, V
    Diago, M
    Marcellin, P
    Ramadori, G
    Bodenheimer, H
    Bernstein, D
    Rizzetto, M
    Zeuzem, S
    Pockros, PJ
    Lin, A
    Ackrill, AM
    ANNALS OF INTERNAL MEDICINE, 2004, 140 (05) : 346 - 355
  • [50] EFFICACY OF PEGINTERFERON ALPHA-2A AND RIBAVIRIN COMBINATION THERAPY IN TREATMENT-NAIVE ESTONIAN PATIENTS WITH CHRONIC HEPATITIS C
    Brjalin, Vadim
    Salupere, Riina
    Tallo, Tatjana
    Kuznetsova, Tatiana
    Priimaegi, Ljudmilla
    Tefanova, Valentina
    CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH, 2012, 20 (02) : 150 - 155
12345